scispace - formally typeset
D

David Baltimore

Researcher at California Institute of Technology

Publications -  882
Citations -  168784

David Baltimore is an academic researcher from California Institute of Technology. The author has contributed to research in topics: RNA & Virus. The author has an hindex of 203, co-authored 876 publications receiving 162955 citations. Previous affiliations of David Baltimore include Thomas Jefferson University & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.

TL;DR: Among several tyrosine-protein kinases, only v-abl could abrogate interleukin 3 dependence of a lymphoblastoid cell line; v-src and v-fps proteins gave partial or no interLEUKin 3 independence, respectively as discussed by the authors.
Journal ArticleDOI

Regulated expression of an immunoglobulin kappa gene introduced into a mouse lymphoid cell line.

TL;DR: A functionally rearranged murine kappa light chain immunoglobulin (Ig) gene is introduced into an Abelson murine leukemia virus-transformed lymphoid cell line and levels of kappa mRNA and polypeptide increased, showing regulated expression of the introduced kappa gene.
Journal ArticleDOI

Requirement of 3'-terminal poly(adenylic acid) for the infectivity of poliovirus RNA.

TL;DR: Ribonuclease H (EC 3.4.1.34) has been used to remove selectively much of the 3'-terminal poly(adenylic acid) [poly(A)] from poliovirus RNA by treating the RNA with the enzyme in the presence of poly(dT), indicating that poly(A) is necessary to the infectivity of the RNA.
Journal ArticleDOI

Binding of Vav to Grb2 through dimerization of Src homology 3 domains

TL;DR: It is reported that both in cell extracts and within intact mammalian cells Vav binds to Grb2 (Sem-5/ASH/Drk), an adaptor molecule which plays a key role in Ras activation.
Journal ArticleDOI

Somatic variants of murine immunoglobulin lambda light chains.

TL;DR: The nucleotide sequence of two λ 1 gene from hybridomas and a λ 2 gene from a myeloma are determined to demonstrate that somatic mutation in λ genes can occur in both the framework and CDR residues.